Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRGP | ENB |
|---|---|---|
| Price | $283.28 | $47.38 |
| Change today | ▲ 0.10% | ▼ 0.99% |
| Market cap | $60.74B | $105.59B |
| Return, 3 months | +6.9% | -11.9% |
| Return, year to date | +55.8% | +7.3% |
| Return, 1 year | +68.1% | +6.2% |
| P/E (TTM) | 27.1 | 25.7 |
| P/B | 16.6 | 2.5 |
| P/E percentile vs own 5y | 49th | 75th |
| Dividend yield | 1.50% | 5.69% |
| Revenue growth (YoY, latest qtr) | +4.2% | +97.1% |
| Net profit growth (YoY) | +22.0% | -32.4% |
| Gross margin | 33.3% | 25.7% |
| Operating margin | 22.9% | 13.6% |
| Net margin | 13.5% | 6.8% |
| Return on equity | 72.3% | 9.7% |
| Analyst target vs. price | +13.5% | +21.7% |
| Analyst buy share | 94% | 57% |
| RSI (14) | 52 | 38 |
| 30-day volatility | 31.2% | 19.0% |
| Max drawdown, 1 year | -16.0% | -15.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.